Matches in SemOpenAlex for { <https://semopenalex.org/work/W4287126189> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W4287126189 abstract "The immune system functions to defend humans against foreign invaders such as bacteria and viruses. However, disorders of the immune system may lead to autoimmunity, inflammatory disease, and cancer. The inflammatory bowel diseases (IBD)-Crohn's disease (CD) and ulcerative colitis (UC)-are chronic diseases marked by relapsing intestinal inflammation. Although IBD is most prevalent in Western countries (1 in 1,000), incident rates are increasing around the world. Through association studies, researchers have linked hundreds of genes to the pathology of IBD. However, the elaborate pathology behind IBD and the high number of potential genes pose significant challenges in finding the best therapeutic targets. Additionally, the tools needed to functionally characterize each genetic association introduce many rate-limiting factors such as the generation of genetically modified mice for each gene. To investigate the therapeutic potential of target genes, a model system has been developed using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated endonuclease (Cas9)-based technologies and a cluster of differentiation 40 (CD40) agonistic antibody. The present study shows that CRISPR/Cas9-mediated editing in the immune system can be used to investigate the impact of genes in vivo. Limited to the hematopoietic compartment, this approach reliably edits the resulting reconstituted immune system. CRISPR/Cas9-edited mice are generated faster and are far less expensive than traditional genetically modified mice. Furthermore, CRISPR/Cas9 editing of mice has significant scientific advantages compared to generating and breeding genetically modified mice such as the ability to evaluate targets that are embryonic lethal. Using CD40 as a model target in the CD40 agonistic antibody-induced colitis model, this study demonstrates the feasibility of this approach." @default.
- W4287126189 created "2022-07-25" @default.
- W4287126189 creator A5057952053 @default.
- W4287126189 creator A5069439269 @default.
- W4287126189 creator A5070812231 @default.
- W4287126189 date "2021-06-02" @default.
- W4287126189 modified "2023-09-27" @default.
- W4287126189 title "Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies" @default.
- W4287126189 doi "https://doi.org/10.3791/61618-v" @default.
- W4287126189 hasPublicationYear "2021" @default.
- W4287126189 type Work @default.
- W4287126189 citedByCount "0" @default.
- W4287126189 crossrefType "journal-article" @default.
- W4287126189 hasAuthorship W4287126189A5057952053 @default.
- W4287126189 hasAuthorship W4287126189A5069439269 @default.
- W4287126189 hasAuthorship W4287126189A5070812231 @default.
- W4287126189 hasConcept C104317684 @default.
- W4287126189 hasConcept C132455925 @default.
- W4287126189 hasConcept C142724271 @default.
- W4287126189 hasConcept C144501496 @default.
- W4287126189 hasConcept C203014093 @default.
- W4287126189 hasConcept C2778260677 @default.
- W4287126189 hasConcept C2779134260 @default.
- W4287126189 hasConcept C54355233 @default.
- W4287126189 hasConcept C70721500 @default.
- W4287126189 hasConcept C71924100 @default.
- W4287126189 hasConcept C86803240 @default.
- W4287126189 hasConcept C8891405 @default.
- W4287126189 hasConcept C98108389 @default.
- W4287126189 hasConceptScore W4287126189C104317684 @default.
- W4287126189 hasConceptScore W4287126189C132455925 @default.
- W4287126189 hasConceptScore W4287126189C142724271 @default.
- W4287126189 hasConceptScore W4287126189C144501496 @default.
- W4287126189 hasConceptScore W4287126189C203014093 @default.
- W4287126189 hasConceptScore W4287126189C2778260677 @default.
- W4287126189 hasConceptScore W4287126189C2779134260 @default.
- W4287126189 hasConceptScore W4287126189C54355233 @default.
- W4287126189 hasConceptScore W4287126189C70721500 @default.
- W4287126189 hasConceptScore W4287126189C71924100 @default.
- W4287126189 hasConceptScore W4287126189C86803240 @default.
- W4287126189 hasConceptScore W4287126189C8891405 @default.
- W4287126189 hasConceptScore W4287126189C98108389 @default.
- W4287126189 hasIssue "172" @default.
- W4287126189 hasLocation W42871261891 @default.
- W4287126189 hasOpenAccess W4287126189 @default.
- W4287126189 hasPrimaryLocation W42871261891 @default.
- W4287126189 hasRelatedWork W2173737475 @default.
- W4287126189 hasRelatedWork W2516842346 @default.
- W4287126189 hasRelatedWork W2527347512 @default.
- W4287126189 hasRelatedWork W2770152187 @default.
- W4287126189 hasRelatedWork W2900771990 @default.
- W4287126189 hasRelatedWork W2943124855 @default.
- W4287126189 hasRelatedWork W2953290252 @default.
- W4287126189 hasRelatedWork W3030388918 @default.
- W4287126189 hasRelatedWork W3120857162 @default.
- W4287126189 hasRelatedWork W4281757975 @default.
- W4287126189 isParatext "false" @default.
- W4287126189 isRetracted "false" @default.
- W4287126189 workType "article" @default.